» Authors » Shun-Ichi Nagata

Shun-Ichi Nagata

Explore the profile of Shun-Ichi Nagata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodaira K, Kakizaki M, Nagata S, Ode H, Okano A, Tamura N, et al.
Vet Anaesth Analg . 2025 Jan; 52(2):174-182. PMID: 39843316
Objective: To investigate the pharmacodynamics and pharmacokinetics of rocuronium administered by bolus injection to sevoflurane-anesthetized horses. Study Design: Prospective, experimental, crossover study. Animals: Five healthy adult Thoroughbred horses (body mass...
2.
Yoshihara T, Tozaki T, Nakaya S, Takasu M, Kawate K, Furukawa R, et al.
J Equine Vet Sci . 2024 Nov; 144():105233. PMID: 39550046
The Taishu horse is a native Japanese breed threatened with extinction. It is important to genotype the causative genes of rare phenotypes in endangered breeds because unique genetic traits might...
3.
Ishii H, Shigematsu R, Takemoto S, Ishikawa Y, Mizobe F, Nomura M, et al.
Curr Drug Metab . 2024 Sep; 25(7):489-504. PMID: 39238378
Objective: Osilodrostat, used to treat Cushing's disease, exhibits an anabolic effect, leading to its classification as a prohibited substance in horseracing and equestrian sports. This study reports the characterization of...
4.
Ishii H, Shigematsu R, Takemoto S, Ishikawa Y, Mizobe F, Nomura M, et al.
Bioanalysis . 2024 Sep; 16(17-18):947-958. PMID: 39235065
The use of osilodrostat, developed as a medication for Cushing's disease but categorized as an anabolic agent, is banned in horses by both the International Federation of Horseracing Authorities and...
5.
Kikuchi M, Murase H, Urata K, Ishige T, Nagata S, Tozaki T, et al.
Domest Anim Endocrinol . 2024 Aug; 89:106879. PMID: 39191115
Circulating microRNAs (miRNAs) are stable in body fluids and can serve as biomarkers for various diseases and physiological states. Although pregnancy-related miRNAs have been identified in various mammals, studies on...
6.
Ishii H, Ishikawa Y, Mizobe F, Nomura M, Yamanaka T, Tanabe S, et al.
Rapid Commun Mass Spectrom . 2024 Feb; 38(5):e9695. PMID: 38355879
Rationale: Osilodrostat is an inhibitor of 11-beta-hydroxylase (CYP11B) and is used for the treatment of Cushing's disease but also categorized as an anabolic agent. The use of osilodrostat is prohibited...
7.
Kikuchi M, Ishige T, Minamijima Y, Hirota K, Nagata S, Tozaki T, et al.
Int J Mol Sci . 2023 Oct; 24(19). PMID: 37833961
Circulating microRNAs (miRNAs) are stable in bodily fluids and are potential biomarkers of various diseases and physiological states. Although several studies have been conducted on humans to detect drug doping...
8.
Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota K, et al.
J Equine Sci . 2023 Oct; 34(3):83-92. PMID: 37781568
Individual identification and paternity testing are important for avoiding inbreeding in the management of small populations of wild and domestic animals. In horse racing industries, they are extremely important for...
9.
Ishige T, Kikuchi M, Kakoi H, Hirota K, Ohnuma A, Tozaki T, et al.
Anim Sci J . 2023 Jul; 94(1):e13854. PMID: 37427667
We evaluated the utility of single nucleotide polymorphism (SNP) markers for parentage testing in Breton (BR) and Percheron (PR) horses in Japan using the proposed International Society for Animal Genetics...
10.
Kakoi H, Kikuchi M, Ishige T, Hirosawa Y, Tanaka S, Nagata S
J Equine Sci . 2023 Jul; 34(2):47-49. PMID: 37405070
To confirm the positive conversion of antibodies against erythrocyte antigens in horses, possible blood transfusion donor horses selected from draft horse populations were periodically monitored with an indirect antiglobulin (Coombs)...